Today I'll be doing an analysis and valuation of Amgen, Inc. ($AMGN), a pharmaceutical company. I'll be utilizing a discounted cash flow model, as well as some income statement analysis, to determine whether or not Amgen is a dividend growth stock or value stock to buy in 2023.
Disclaimer: This is an analysis done for fun. I am not a financial advisor nor am I advocating for any particular investment in this video or any other of my videos.
Start your investment journey With 2 free stocks. Open an account and get a free stock! Deposit and get another free stock! [ Ссылка ]
Join me on Yotta using my username DAVID443 and we’ll both get a Loot Box with up to $100 and 1 MILLION tickets into daily number drawings with prizes up to $1m. Yotta is an app featured in Bloomberg and Forbes with over 700k users. [ Ссылка ]
#investing #personalfinance #stockmarket #stocks #stockstobuy #stockstowatch #valueinvesting #financialeducation #pharmastocks #dividendstocks #dividendinvesting
Amgen Stock Analysis | Should You Buy $AMGN? | Top Pharma Stocks
Теги
amgn stockamgn stock analysisamgnamgenamgen stock analysisamgen stock reviewbig pharma stockstop pharma stocksamgen stockpharma stocks to buy nowpharma stockspharma stocks 2023pharma stocks for long termdavid marquezpharmaceutical stockspharmaceutical stocks to buypharmaceutical stocks to buy nowbest pharmaceutical stockshealthcare stocks to buy nowhealthcare stocks 2023best pharma stocksdcf modeldiscounted cash flowstock review